SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019796
Filing Date
2024-05-15
Accepted
2024-05-15 16:01:03
Documents
87
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1074856
2 ex10-5.htm EX-10.5 111874
3 ex10-6.htm EX-10.6 170136
4 ex10-7.htm EX-10.7 535065
5 ex10-8.htm EX-10.8 36751
6 ex10-9.htm EX-10.9 51917
7 ex31-1.htm EX-31.1 18630
8 ex31-2.htm EX-31.2 18852
9 ex32-1.htm EX-32.1 4215
10 ex32-2.htm EX-32.2 6566
  Complete submission text file 0001493152-24-019796.txt   6441629

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE vbiv-20240331.xsd EX-101.SCH 51399
12 XBRL CALCULATION FILE vbiv-20240331_cal.xml EX-101.CAL 63852
13 XBRL DEFINITION FILE vbiv-20240331_def.xml EX-101.DEF 175302
14 XBRL LABEL FILE vbiv-20240331_lab.xml EX-101.LAB 339556
15 XBRL PRESENTATION FILE vbiv-20240331_pre.xml EX-101.PRE 280221
91 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 678662
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 24950096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)